The survival rate for one year patients and grafts was 77.8% and 55.6% in CsA treated group, and 87.5% and 75% in ALG treated group, respectively.

• 环孢素A（CsA）组和抗淋巴细胞球蛋白组人/肾1年存活率分别为77.；8%25/55